Related Experiment Video
Updated: Jan 13, 2026

06:11
Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
2.3K
microRNA Biomarkers in Paediatric Infection Diagnostics-Bridging the Gap Between Evidence and Clinical Application: A
Oenone Rodgers1, Anna De Beer2, Thomas Waterfield1
1Wellcome-Wolfson Institute for Experimental Medicine at Queen's University Belfast, Belfast BT9 7BL, UK.
Non-Coding RNA
|October 28, 2025
Summary
MicroRNAs (miRNAs) show promise as biomarkers for distinguishing bacterial from viral infections in children. Rigorous study design is crucial for their clinical translation in pediatric infectious disease diagnostics.
Area of Science:
- Biochemistry
- Molecular Biology
- Pediatrics
Background:
- Differentiating pediatric bacterial and viral infections is challenging, often leading to antibiotic overuse.
- Rising antimicrobial resistance necessitates novel diagnostic biomarkers.
- Host microRNAs (miRNAs) are emerging as potential indicators of infection type.
Purpose of the Study:
- To review current host miRNA biomarkers for acute bacterial and viral infections in children (0-18 years).
- To analyze study methodologies, diagnostic performance, and identify research gaps for clinical application.
Main Methods:
- A scoping review of 1147 identified articles, including 36 studies.
- Focused on studies examining host miRNAs in pediatric infections.
- Evaluated study designs, diagnostic accuracy metrics, and reported miRNA candidates.
Main Results:
- 17 miRNAs were validated in multiple studies; 3 (hsa-miR-182-5p, hsa-miR-363-3p, hsa-miR-206) linked to bacterial infections.
- 9 miRNAs (e.g., hsa-miR-155, hsa-miR-29a-3p) associated with viral infections.
- Reported sensitivities (70-100%) and specificities (72-100%) show biomarker potential, with AUCs ranging from 0.62 to 0.99.
Conclusions:
- miRNA biomarkers hold significant potential for diagnosing pediatric infections with rigorous validation.
- Clinical translation is hindered by inconsistent adherence to reporting guidelines (STARD) and study heterogeneity.
- Case-control designs, common in current research, may identify non-specific markers, limiting diagnostic utility.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K

